CP Gross, MS Andersen, HM Krumholz, GJ … - Jama, 2006 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 56 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org HK Sanoff, H Bleiberg, RM Goldberg - Journal of Clinical Oncology, 2007 - jcojournal.org Colorectal cancer (CRC) is predominantly a disease of older persons, and our
population is aging. Physicians and their older patients commonly face the
dilemma of whether or not to give/receive systemic chemotherapy for CRC. ... Cited by 29 - Related articles - All 6 versions
- ►nih.gov C Vogeli, AE Shields, TA Lee, TB Gibson, WD … - Journal of General Internal Medicine, 2007 - Springer Christine Vogeli, PhD 1,2 , Alexandra E. Shields, PhD 1,2 , Todd A. Lee, PharmD
PhD 4,5 , ... Teresa B. Gibson, PhD 3 , William D. Marder, PhD 3 , Kevin B.
Weiss, MD MPH 4,5 , ... 1 Institute for Health Policy in the Department of ... Cited by 16 - Related articles - BL Direct - All 5 versions
U Wedding, B Röhrig, A Klippstein, L Pientka, … - Journal of Cancer Research and Clinical Oncology, 2007 - Springer Abstract Purpose With the increasing number of elderly patients suVering from
cancer, comorbidity and functional impair- ment become common problems in
patients with cancer. Both comorbidity and functional impairment are ... Cited by 13 - Related articles - BL Direct - All 2 versions
- ►jcojournal.org NL Keating, MB Landrum, CN Klabunde, RH … - Journal of Clinical Oncology, 2008 - jcojournal.org Methods National survey of surgeons and medical oncologists caring for patients
with colorectal cancer regarding whether they would recommend adjuvant
chemotherapy for hypothetical patients with stage III colon cancer who ... Cited by 9 - Related articles - BL Direct - All 4 versions
RS Braithwaite, J Concato, CC Chang, MS … - Archives of Internal Medicine, 2007 - archinte.highwire.org Methods We outline a framework using a payoff time, which we define as the
minimum elapsed time until the cumulative incremental benefits of a guideline
exceed its cumulative incremental harms. If the payoff time of a guideline ... Cited by 8 - Related articles - BL Direct - All 3 versions
G Goldzweig, A Hubert, N Walach, B Brenner, S … - Critical Reviews in Oncology and Hematology, 2009 - Elsevier The population in the western world has been aging while the cancer survival
rates have been systematically increasing. Knowledge is lacking about
psychological processes and effects of gender difference among middle-aged ... Cited by 6 - Related articles - All 24 versions
NM Hadler, 2008 - books.google.com This book was published with the assistance of the H. Eugene and Lillian Youngs
Lehman Fund of the University of North Carolina Press. A complete list of books
published with the assistance of the Lehman Fund appears at the end of the ... Cited by 6 - Related articles
JJ Fenton, Y Cai, P Green, LA Beckett, P … - American Journal of Preventive Medicine, 2008 - Elsevier The annual use of FOBT and sigmoidoscopy declined from 1995 to 2003 in all
racial/ethnic groups, but the relative decline in sigmoidoscopy use was greater
among whites compared to nonwhites. In contrast, colonoscopy use increased ... Cited by 5 - Related articles - All 20 versions
MA Raji, YF Kuo, JL Freeman, JS Goodwin - Archives of Internal Medicine, 2008 - Am Med Assoc Results Seven percent of our sample had preexisting dementia diagnoses. Survival
after a cancer diagnosis was markedly worse in demented than in nondemented
patients. Most of the excess deaths came from noncancer causes; 33.3% of ... Cited by 6 - Related articles - All 6 versions
